Abstract
An efficient strategy for the construction of C13-oxidized cembrenolides is reported. Central to this strategy is the installation of the C13 hydroxyl group prior to cembrane macrocyclization (via formation of the C1–C2 bond), allowing access to both C13 alcohol epimers. The orientation of the C13 alcohol was found to influence the cyclization mode of the cembranolide scaffold upon furan oxidation, leading to motifs reminiscent to bipinnatolide F, bielschowskysin, and verrillin.
Keywords: Cembrane, Macrocyclization, Furan oxidation, Anomeric effect, Hemiketal
Isolated from soft corals and octocorals, cembrenolides constitute a large family of natural products that are typified by a 14-membered cembrane skeleton. Oxidations at the periphery of this framework set the stage for various skeletal rearrangements and transannular cyclizations ultimately producing a wide array of polycyclic metabolites.1 In addition to their ecological impact,2 these compounds have been pursued both for their unusual structural motifs and for their biological and pharmacological potential. 1a,3 For instance, oxidation at the C13 center of the cembrane motif is found in several structurally intricate and biologically unexplored cembrenolides ( Fig. 1).2a Among them, bielschowskysin (1), a complex hexacyclic cembrane, was shown to exhibit very potent cytotoxicity against nonsmall cell lung cancer (EKVX, GI50 ca. 10 nM) and renal cancer (CAKI-1, GI50 ca. 0.5 μM).4,5 Moreover, 1 has demonstrated potent anti-malarial activity against Plasmodium falciparum (IC50 ca. 10 μg/ml).4 Lophotoxin (4)6 was found to be a potent nicotinic acetylcholine receptor inhibitor with an LD50 of 8 mg/kg2a in mice and, since its isolation, it has become a synthetic conundrum.7 On the other hand, the bioactivities of verrillin (2)8 and bipinnatolide F (3)9 have not yet been fully explored.
Figure 1.
Proposed biosynthetic pathway to bielshowskysin and verrillin.
Evaluation of the polycyclic motifs of bielschowskysin (1) and verrillin (2) suggests that both compounds can derive biosynthetically from the same precursor 5a (R1 = Me) whose cembrane macrocycle contains a furan in close proximity to a butenolide ring ( Fig. 2). Furan oxidation of 5a could produce intermediate 6 in which the electron rich enol could react with the pendant butenolide to form intermediate 7. If the C13 β-alcohol is modified as an acetate (R2 = OAc), the resulting C12 carbanion could cyclize at the C6 center creating the strained cyclobutane motif reminiscent to that found in 1.1b,c Both photochemical5a–c and Lewis-acid induced conditions10 could account for the formation of this ring. However, if the C13 β-alcohol is available (R2 = H), it could cyclize at the C6 center of 7, forming a more structurally favorable six membered hemiketal ring encountered in the motif of verrillin (2).
Figure 2.
Proposed biosynthetic pathway to bielshowskysin and verrillin.
The combination of structural intricacy and biological potential of these metabolites prompted our studies toward the synthesis of the C13 oxidized cembranolide 5b (R1 = H). From a synthetic standpoint, 5b could derive from the union of three components: (a) a C7–C12 fragment containing a masked butenolide; (b) a C13–C1 aldehyde motif; and (c) a C2–C6 framework containing a furan ring.
The synthesis of 5b began with construction of the C7–C12 fragment 11, in which the butenolide ring is introduced as an α-selenolactone (Scheme 1).7d To this end, propargyl ester 8, available from but-3-yn-1-ol in 3 steps,11 was reduced to saturated ester 9 using excess NaBH4 and CuI12 (Scheme 1). The crude material was then treated with cat. TsOH in benzene to form γ-lactone 10 (79% yield over two steps). It is worth noting that this approach represents a significant improvement over the previously reported synthesis of compound 10.13 Treatment of 10 with LiHMDS/PhSeBr then afforded 11 in 76% yield.7f,13
Scheme 1.
Reagents and conditions: (a) 6 equiv NaBH4, 2 equiv CuI, MeOH, −78 °C, 15 min; (b) 0.1 equiv TsOH, PhH, 25 °C, 30 min, 79% (over 2 steps); (c) 1.1 equiv LiHMDS, −78 °C, then 1 equiv PhSeBr, THF, −78 to 25 °C, 30 min, 76%.
Aldehyde 15, representing the C13–C1 component, was prepared beginning from propargyl alcohol 12 (Scheme 2). Methyl zirconation/iodination14 of 12 followed by protection of the pendant allylic alcohol afforded 13 in 50% combined yield. Lithiation of the resulting vinyl iodide and quenching of the reaction with oxirane yielded 14 in 55% yield.15 Oxidation of 14 with Dess–Martin periodinane16 cleanly afforded β,γ-unsaturated aldehyde 15 that was used without further purification.
Scheme 2.

Reagents and conditions: (a) (i) 2.5 equiv Me3Al, 0.2 equiv Cp2ZrCl2, DCE, 25 °C, 24 h, then 2.0 equiv I2, −40 °C, 30 min, (ii) 1.1 equiv TBSCl, 3.0 equiv imid, DCM, 0 °C, 1 h, 50% (over 2 steps); (b) 2.0 equiv t-BuLi, PhMe, −78 °C, 30 min, then oxirane (excess), −78 to 25 °C over 30 min, 55%; (c) 1.3 equiv Dess–Martin [O], 6.0 equiv NaHCO3, 25 °C, 20 min, 95%.
The construction of the C13-hydroxylated cembrenolide motif via sequential coupling of the three components is described in Scheme 3. Compound 11 was lithiated at the C12 center (LiHMDS, −78 °C) and alkylated with aldehyde 15 to produce 16 as a mixture of 4 diastereomers. The crude mixture was oxidatively de-selenated7d,17 to afford butenolide 17 as a 1:1 mixture of C13 diastereomers (17a, 17b) that were easily separated by column chromatography (78% combined yield). The stereochemistry of the C13 hydroxyl group was determined after macrocyclization (see Scheme 4). Protection of 17a and 17b with TBSCl produced the di-silylated compounds that, after selective deprotection of the primary TBS group using PPTS in ethanol,18 produced primary alcohols 18a and 18b (ca. 82% yield over 2 steps).
Scheme 3.
Reagents and conditions: (a) 1.1 equiv LiHMDS, THF, −78 °C, 1 h, then 15, −78 °C, 20 min; (b) 1.5 equiv H2O2, 10 equiv NaHCO3, THF/EtOAc 1:1, 25 °C, 10 min, 78% (over 2 steps); (c) (i) 1.1 equiv TBSCl, 3.0 equiv imid, DCM, 25 °C, 12 h; (ii) 1.0 equiv PPTS, EtOH, 25 °C, 12 h, 82% (over 2 steps); (d) 4 mol % Pd(PPh3)4, 4 mol % CuI, then 19, DMF, 25 °C, 2 h, 75%; (e) 1.1 equiv NBS, 1.1 equiv PPh3, DCM, −20 °C, 30 min, 88%; (f) 12.0 equiv CrCl2, 3.0 equiv NiCl2(DME), THF, 25 °C, 12 h, 83%.
Scheme 4.
Reagents and conditions: (a) 5.0 equiv Et3N·3HF, MeCN, mw 80 °C, 20 min, 91%; (b) 1.2 equiv TFA, 1.5 equiv TESH, DCM, 0 °C, 15 min, 81%; (c) 1.3 equiv TBHP, 0.05 equiv Triton B, THF, 0 °C, 70%.
Coupling of compounds 18a and 18b with stannylated furfural 19 was performed via a modified Stille reaction19 (Scheme 3) to afford 20a and 20b in 75% average yield. Bromination of the allylic alcohol using Appel conditions20 produced allylic bromides 21a and 21b in 88% yield. We were concerned that the presence of the new C13 stereocenter, containing a bulky TBS ether on a linear uncyclized motif, might disrupt the high diastereoselectivity of the macrocylization that has been observed in previous systems.21 However, to our satisfaction, this macrocylization proceeded smoothly using CrCl2/NiCl2(DME) and formed compound 22a and 22b in 83% average yield. As was previously observed,21 the diastereoselectivity of this reaction is controlled by the chirality of the butenolide motif.
Removal of the extraneous silyl group was achieved using TEA-buffered HF reagent22 under microwave irradiation conditions. This treatment afforded cleanly diols 23a and 23b in 91% average yield. (Scheme 4). Reduction of the furylic C2 alcohol of 23a and 23b with TFA and TESH gave rise to 24a and 24b respectively, the stereochemistry of which was determined via a single crystal X-ray analysis.23 Epoxidation across the C11–C12 alkene proceeded selectively under TBHP/Triton B conditions,24 to create, irrespectively of the orientation of the adjacent C13 alcohol, α-epoxides 25a and 25b (70% average yield).
We then explored the effect of the C13 hydroxyl functionality during oxidative cyclizations of furanocembrenolides (Scheme 5).25 With an eye toward the scaffold of bipinnatolide F (3), we treated 23b under oxidative conditions mediated by CAN5c,26 (benzene/water: 20/1 at 10 °C). Unfortunately, only a complex mixture of products was observed. On the other hand, when identical oxidative conditions were applied to 23a, containing the C13-hydroxyl group at the α-face of the cembranolide scaffold, we observed the formation of 5,6-spiro ketal 27.23 This spiroketal motif is presumably stabilized by the diaxial orientation of the ketal oxygens (anomeric effect), despite the axial orientation of the C13 butenolide side chain. Motif 27 is similar to 6, a proposed intermediate in the biosynthesis of bielschowskysin (1) and verrillin (2),1b,c where the C6–C7 enol ether is proposed to undergo cyclization with the C11–C12 butenolide to furnish the strained cyclobutane motif. Interestingly, CAN-mediated oxidation5c,26 of 25b (benzene/water: 20/1 at 10 °C) led to isolation of compound 2623 in which an intermediate enedione, produced upon furan oxidation, underwent hemiketalization at the C3 center by the pendant C13 β-hydroxyl group. Hemiketal 26 is stabilized by the diaxial orientation of the oxygen substituents (anomeric effect)27 and by the equatorial orientation of the C1 and C13 side-chains. As projected, the structure of 26 is reminiscent to that of bipinnatolide F (3).6
Scheme 5.
Reagents and conditions: (a) 2.0 equiv CAN, PhH/H2O 20:1, 0 °C, 15 min, 50%; (b) 2.0 equiv CAN, PhH/H2O 20:1, 0 °C, 20 min, 77%.
In conclusion, we present here an efficient strategy toward C13-oxidized cembrane scaffolds that paves the way for the synthesis of complex cembrenolides. The developed approach allows construction of such scaffolds in 13 steps from readily available starting materials. Our studies suggest that the stereochemistry of the C13 hydroxyl group affects the mode of cyclization upon oxidation of the furan-containing starting materials. The resulting polycyclic motifs bear structural similarities to more intricate natural products. These studies could set the stage for a divergent, biomimetic synthesis of various bioactive natural products of the cembrenolide family.
Supplementary Material
Acknowledgments
We gratefully acknowledge the National Institutes of Health (NIH) for financial support of this work through Grant Number R01 GM081484. We thank the National Science Foundation for instrumentation Grants CHE9709183 and CHE0741968. We also thank Dr. Anthony Mrse (UCSD NMR Facility), Dr. Yongxuan Su (UCSD MS Facility) and Dr. Arnold L. Rheingold and Dr. Curtis E. Moore (UCSD X-ray Facility).
Footnotes
Supplementary data (detailed experimental procedures, spectral characterization, and copies of 1H and 13C NMR data) associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.tetlet.2013.01.085.
References and notes
- 1.For selected recent reviews see: Roethle PA, Trauner D. Nat Prod Rep. 2008;25:298–317. doi: 10.1039/b705660p.Li Y, Pattenden G. Nat Prod Rep. 2011;28:429–440. doi: 10.1039/c0np00029a.Li Y, Pattenden G. Nat Prod Rep. 2011;28:1269–1310. doi: 10.1039/c1np00023c.Lakshmi V, Kumar R. Nat Prod Res. 2009;23:801–850. doi: 10.1080/14786410802137135.
- 2.(a) Abramson SN, Fenical W, Taylor P. Drug Dev Res. 1991;24:297–312. [Google Scholar]; (b) Su JH, Wen ZH. Mar Drugs. 2011;9:944–951. doi: 10.3390/md9060944. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.(a) Kamel HN, Slattery M. Pharm Biol. 2005;43:253–269. [Google Scholar]; (b) Ahmed AF, Shiue RT, Wang GH, Dai CF, Kuo YH, Sheu JH. Tetrahedron. 2003;59:7337–7344. [Google Scholar]
- 4.Marrero J, Rodriguez AD, Baran P, Raptis RG, Sanchez JA, Ortega-Barria E, Capson TL. Org Lett. 2004;6:1661–1664. doi: 10.1021/ol049495d. [DOI] [PubMed] [Google Scholar]
- 5.(a) Doroh B, Sulikowski GA. Org Lett. 2006;8:903–906. doi: 10.1021/ol0530225. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Miao R, Gramani SG, Lear MJ. Tetrahedron Lett. 2009;50:1731–1733. [Google Scholar]; (c) Nicolaou KC, Adsool VA, Hale CRH. Angew Chem, Int Ed. 2011;50:5149–5152. doi: 10.1002/anie.201101360. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Farcet JB, Himmelbauer M, Mulzer J. Org Lett. 2012;14:2195–2197. doi: 10.1021/ol3006419. [DOI] [PubMed] [Google Scholar]
- 6.Fenical W, Okuda RK, Bandurraga MM, Culver P, Jacobs RS. Science. 1981;212:1512–1514. doi: 10.1126/science.6112796. [DOI] [PubMed] [Google Scholar]
- 7.For selected synthetic approaches towards 4 see: Tius MA, Trehan S. J Org Chem. 1986;51:765–767.Paterson I, Gardner M, Banks BJ. Tetrahedron. 1989;45:5283–5292.Paterson I, Brown RE. Tetrahedron Lett. 1999;40:5807–5810.Wipf P, Soth MJ. Org Lett. 2002;4:1787–1790. doi: 10.1021/ol025861m.Wipf P, Grenon M. Can J Chem. 2006;84:1226–1241.Cases M, de Turiso FGL, Pattenden G. Synlett. 2001:1869–1872.
- 8.Rodriguez AD, Shi YP. J Org Chem. 2000;65:5839–5842. doi: 10.1021/jo000397p. [DOI] [PubMed] [Google Scholar]
- 9.Rodriguez AD, Shi JG, Huang SD. J Nat Prod. 1999;62:1228–1237. doi: 10.1021/np990064r. [DOI] [PubMed] [Google Scholar]
- 10.(a) Ihara M, Taniguchi T, Makita K, Takano M, Ohnishi M, Taniguchi N, Fukumoto K, Kabuto C. J Am Chem Soc. 1993;115:8107–8115. [Google Scholar]; (b) Ihara M, Taniguchi T, Tokunaga Y, Fukumoto K. J Org Chem. 1994;59:8092–8100. [Google Scholar]; (c) Inanaga K, Takasu K, Ihara M. J Am Chem Soc. 2005;127:3668–3669. doi: 10.1021/ja042661s. [DOI] [PubMed] [Google Scholar]
- 11.(a) Roethle PA, Trauner D. Org Lett. 2006;8:345–347. doi: 10.1021/ol052922i. [DOI] [PubMed] [Google Scholar]; (b) Saitman A, Rulliere P, Sullivan SDE, Theodorakis EA. Org Lett. 2011;13:5854–5857. doi: 10.1021/ol202476j. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.(a) Lin L, Zhao QY, Li AN, Ren FB, Yang FZ, Wang R. Org Biomol Chem. 2009;7:3663–3665. doi: 10.1039/b909418k. [DOI] [PubMed] [Google Scholar]; (b) Jian YJ, Wu YK. Org Biomol Chem. 2010;8:811– 821. doi: 10.1039/b923123d. [DOI] [PubMed] [Google Scholar]
- 13.Tang B, Bray CD, Pattenden G. Org Biomol Chem. 2009;7:4448–4457. doi: 10.1039/b910572g. [DOI] [PubMed] [Google Scholar]
- 14.Negishi E, Ma SM, Sugihara T, Noda Y. J Org Chem. 1997;62:1922–1923. doi: 10.1021/jo970009s. [DOI] [PubMed] [Google Scholar]
- 15.Andresen G, Eriksen AB, Dalhus B, Gundersen LL, Rise F. J Chem Soc, Perkin Trans 1. 2001:1662–1672. [Google Scholar]
- 16.Dess DB, Martin JC. J Org Chem. 1983;48:4155–4156. [Google Scholar]
- 17.Weinstabl H, Gaich T, Mulzer J. Org Lett. 2012;14:2834–2837. doi: 10.1021/ol301068h. [DOI] [PubMed] [Google Scholar]
- 18.Crouch RD. Tetrahedron. 2004;60:5833–5871. [Google Scholar]
- 19.During optimization of this reaction we found that using cesium fluoride, a common additive in stannane-mediated couplings, led to decomposition of the compounds and thus, it was not used.
- 20.Appel R. Angew Chem, Int Ed. 1975;14:801–811. [Google Scholar]
- 21.(a) Huang QH, Rawal VH. Org Lett. 2006;8:543–545. doi: 10.1021/ol053054s. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Paquette LA, Astles PC. J Org Chem. 1993;58:165–169. [Google Scholar]; (c) Rayner CM, Astles PC, Paquette LA. J Am Chem Soc. 1992;114:3926–3936. [Google Scholar]
- 22.Gaynor JW, Brazier J, Cosstick R. Nucleosides Nucleotides Nucleic acids. 2007;26:709–712. doi: 10.1080/15257770701490753. [DOI] [PubMed] [Google Scholar]
- 23.CCDC 888992 (24a), 888994 (24b), 905462 (26), and 905463 (27) contain the Supplementary crystallographic data. This information can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/products/csd/request/. In the figures some hydrogen atoms have been omitted for clarity.
- 24.Yoshimitsu T, Nojima S, Hashimoto M, Tsukamoto K, Tanaka T. Synthesis. 2009;17:2963–2969. [Google Scholar]
- 25.(a) Tofi M, Koltsida K, Vassilikogiannakis G. Org Lett. 2009;11:313–316. doi: 10.1021/ol8024742. [DOI] [PubMed] [Google Scholar]; (b) Montagnon T, Tofi M, Vassilikogiannakis G. Acc Chem Res. 2008;41:1001– 1011. doi: 10.1021/ar800023v. [DOI] [PubMed] [Google Scholar]
- 26.Nicolaou KC, Hale CRH, Ebner C, Nilewski C, Ahles C, Rhoades D. Angew Chem, Int Ed. 2012;51:4726–4730. doi: 10.1002/anie.201201538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.For selected monographs see: The Anomeric Effect and Related Stereoelectronic Effects; Thatcher GRJ, editor. ACS Symposium Series. 1993;539Juaristi E, Cuevas G. Tetrahedron. 1992;48:5019–5087.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






